STOCK TITAN

Bristol Myers Squibb Announces Dividend Increase

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
dividends
Rhea-AI Summary
Bristol Myers Squibb (BMY) has declared a quarterly dividend of $0.60 per share on its common stock, representing a 5.3% increase over last year's rate. The annual dividend rate for the fiscal year 2024 is $2.40 per share. This marks the 15th consecutive year of dividend increases and the 92nd consecutive year of paying dividends.
Positive
  • 15th consecutive year of dividend increases
  • 92nd consecutive year of paying dividends
Negative
  • None.

PRINCETON, N.J.--(BUSINESS WIRE)-- Bristol Myers Squibb (NYSE: BMY) today announced that its Board of Directors has declared a quarterly dividend of sixty cents ($0.60) per share on the $0.10 par value common stock of the company. The dividend is payable on February 1, 2024, to stockholders of record at the close of business on January 5, 2024.

This quarterly dividend represents a 5.3% increase over last year’s quarterly rate of fifty-seven cents ($0.57) per share. At this quarterly dividend rate, subject to the normal quarterly review by the Board of Directors, the annual dividend rate for the fiscal year 2024 is $2.40 per share. This marks the 15th consecutive year that the company has increased its dividend and the 92nd consecutive year that the company has paid a dividend.

In addition, the Board of Directors has declared a quarterly dividend of fifty cents ($0.50) per share on the company’s $2.00 convertible preferred stock, payable on March 1, 2024, to stockholders of record at the close of business on January 30, 2024.

About Bristol Myers Squibb Company

Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube, Facebook, and Instagram.

corporatefinancial-news

Media:

media@bms.com



Investors:

investor.relations@bms.com

Source: Bristol Myers Squibb

Bristol Myers Squibb (BMY) has declared a quarterly dividend of $0.60 per share on its common stock.

The current quarterly dividend represents a 5.3% increase over last year’s quarterly rate of $0.57 per share.

This marks the 15th consecutive year that the company has increased its dividend.

This marks the 92nd consecutive year that the company has paid a dividend.
Bristol-Myers Squibb Co.

NYSE:BMY

BMY Rankings

BMY Latest News

BMY Stock Data

Pharmaceutical Preparation Manufacturing
Manufacturing
Link
Health Technology, Pharmaceuticals: Major, Manufacturing, Pharmaceutical Preparation Manufacturing
US
New York

About BMY

The Bristol-Myers Squibb Company is an American multinational pharmaceutical company. Headquartered in New York City, BMS is one of the worlds largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations. For fiscal 2022, it had a total revenue of $46.2 billion.